Implementation of immunotherapy in recurrent endometrial cancer: a real-world cohort study.

Am J Obstet Gynecol

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania Health Systems, Philadelphia, PA; Department of Obstetrics and Gynecology, University of Pennsylvania Health Systems, Philadelphia, PA; Leonard Davis Institute of Health Economics, University of Pennsylvania Health Systems, Philadelphia, PA; Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania Health Systems, Philadelphia, PA; Abramson Cancer Center, Pennsylvania Hospital, Philadelphia, PA.

Published: November 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2024.07.004DOI Listing

Publication Analysis

Top Keywords

implementation immunotherapy
4
immunotherapy recurrent
4
recurrent endometrial
4
endometrial cancer
4
cancer real-world
4
real-world cohort
4
cohort study
4
implementation
1
recurrent
1
endometrial
1

Similar Publications

Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers.

Cancer Biol Med

January 2025

State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.

Objective: Esophageal cancer (EC) ranks eighth among cancers in cancer-related deaths globally, and ~44% of new cases occur in China. We sought to describe the clinical characteristics and treatment landscape of EC in China before the approval of immunotherapy in 2020.

Methods: CHANNEL was a large, retrospective study using patient-level data from 14 hospitals/cancer centers across China, including adults initiating therapy for newly diagnosed EC (January to December 2018).

View Article and Find Full Text PDF

[Expert recommendations on mass population vaccination].

Zhonghua Yu Fang Yi Xue Za Zhi

January 2025

National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing100050, China.

Mass vaccination represents a highly effective strategy for accelerating disease control while simultaneously reducing incidence and mortality rates. By developing comprehensive plans and standards for mass vaccination, it is feasible to optimize resource allocation and swiftly enhance vaccination coverage, thereby preventing, controlling, or interrupting outbreaks or epidemics of specific infectious diseases. To standardize the mass vaccination process and establish a population immunity barrier in an orderly, efficient, and safe manner, a panel of experts was convened to develop the Recommendations on Mass Vaccination.

View Article and Find Full Text PDF

In April 2024, the Adult Immunization Board convened a technical meeting to explore the latest strategies and identify exemplary approaches regarding the implementation of vaccines for adults into Europe's National Immunization Programs (NIPs). The meeting was built around three pillars: decision making for introducing a new vaccine, implementation, monitoring, and evaluation. The increasing number of new vaccines available in a context of competing health priorities warrants transparent and evidence-based decision-making processes for vaccine introduction.

View Article and Find Full Text PDF

Objective: To describe the polio vaccination status in 26 state capitals, the Federal District, and 12 municipalities in Brazil, among children born between 2017 and 2018.

Methods: This was a population-based household survey conducted from 2020 to 2022, which assessed polio vaccination coverage in children, considering valid, administered, and timely doses by municipality.

Results: Data were collected from 37,801 children.

View Article and Find Full Text PDF

Background: Metabolic pathways are known to significantly impact the development and advancement of lung cancer. This study sought to establish a signature related to butyrate metabolism that is specifically linked to lung adenocarcinoma (LUAD).

Methods: For the purpose of identifying butyrate metabolism-related differentially expressed genes (BMR-DEGs) in the TCGA-LUAD dataset, we introduced transcriptome data.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!